Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Houston (Lenalidomide)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Houston, Texas
    Baylor College of Medicine
Jan 16, 2018

NSCLC Trial in India, United States (anamorelin HCl, )

Completed
  • Carcinoma, Non-Small-Cell Lung
  • anamorelin HCl
  • placebo
  • Little Rock, Arkansas
  • +32 more
Apr 12, 2017

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in Worldwide (ZD6474, Paclitaxel, Carboplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Concord, California
  • +33 more
Aug 24, 2016

Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck Trial in United States (Prexasertib)

Completed
  • Advanced Cancer
  • +5 more
  • Sarasota, Florida
  • +4 more
May 9, 2016

NSCLC Trial in United States (Patupilone)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Louisville, Kentucky
  • +3 more
Jan 6, 2014

Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell Trial in Worldwide (CP-751,871 (Figitumumab),

Terminated
Has Results
  • Carcinoma, Squamous Cell
  • +3 more
  • CP-751,871 (Figitumumab)
  • +2 more
  • Florence, Alabama
  • +279 more
Dec 11, 2013

NSCLC, Lung Cancer Trial in Rochester, Houston (Nexavar (Sorafenib, BAY43-9006), Bevacizumab, Paclitaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Lung Cancer
  • Nexavar (Sorafenib, BAY43-9006)
  • +3 more
  • Rochester, Minnesota
  • +1 more
Nov 12, 2013

NSCLC Trial in Worldwide (CP-751,871, paclitaxel, carboplatin)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Tucson, Arizona
  • +30 more
Oct 1, 2013

NSCLC Trial in United States (XL184, erlotinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Anchorage, Alaska
  • +12 more
Sep 17, 2013

NSCLC Trial in United States (TRAIL-R1 mAb (TRM-1;HGS-ETR1))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • TRAIL-R1 mAb (TRM-1;HGS-ETR1)
  • Denver, Colorado
  • +4 more
Aug 1, 2013

NSCLC Trial in Worldwide (erlotinib, sunitinib, )

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +31 more
Jan 31, 2013

NSCLC Trial in United Kingdom, United States (Tarceva, carboplatin, paclitaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Alhambra, California
  • +42 more
Aug 6, 2012

Carcinoma, Non-small-cell Lung Trial in Tucson, Los Angeles, Houston (TLK286)

Completed
  • Carcinoma, Non-small-cell Lung
  • Tucson, Arizona
  • +2 more
Jul 21, 2011

Carcinoma, Non-small-cell Lung Trial in Los Angeles, Indianapolis, Houston (TLK286 in combination with docetaxel)

Completed
  • Carcinoma, Non-small-cell Lung
  • TLK286 in combination with docetaxel
  • Los Angeles, California
  • +3 more
Jul 21, 2011

NSCLC Trial in United States (gemcitabine/Eloxatin (GEMOX), carboplatin/paclitaxel (CP))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • gemcitabine/Eloxatin (GEMOX)
  • carboplatin/paclitaxel (CP)
  • Birmingham, Alabama
  • +69 more
Apr 15, 2009

NSCLC Trial in Houston (Cetuximab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Houston, Texas
    Veeda Oncology
Aug 20, 2008

NSCLC Trial in Worldwide (Gemcitabine, LY293111, cisplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +18 more
Dec 17, 2007

Brain Tumors, NSCLC, Metastases, Tumor Trial in Worldwide (Motexafin Gadolinium)

Completed
  • Brain Neoplasms
  • +2 more
  • Motexafin Gadolinium
  • Phoenix, Arizona
  • +91 more
May 4, 2007

NSCLC Trial in Houston (ALIMTA, Carboplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Houston, Texas
    (unnamed)
Jul 18, 2006